FOI 7337 - biologic and biosimilar products within Rheumatology
Date: 25 April 2022 to 25 April 2025
It would be really helpful if you could provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:
- Abatacept [Orencia]
- Adalimumab [Humira]
- Adalimumab Biosimilars
- Apremilast [Otezla]
- Baricitinib [Olumiant]
- Certolizumab [Cimzia]
- Etanercept [Enbrel]
- Etanercept Biosimilars
- Filgotinib [Jyseleca]
- Golimumab [Simponi]
- Guselkumab [Tremfya]
- Infliximab [Remicade]
- Infliximab Biosimilars
- Ixekizumab [Taltz]
- Risankizumab [Skyrizi]
- Rituximab [MabThera]
- Rituximab Biosimilars
- Sarilumab [Kevzara]
- Secukinumab [Cosentyx]
- Tocilizumab [Ro Actemra]
- Tofacitinib [Xeljanz]
- Upadacitinib [Rinvoq]
- Ustekinumab [Stelara]
- Request ID:7337
- Category:Clinical - Drugs
- Response:
May 2022
Thank you for your recent request under the Freedom of Information Act 2000.
The information you have requested is as follows:
It would be really helpful if you could provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:
- Abatacept [Orencia]
- Adalimumab [Humira]
- Adalimumab Biosimilars
- Apremilast [Otezla]
- Baricitinib [Olumiant]
- Certolizumab [Cimzia]
- Etanercept [Enbrel]
- Etanercept Biosimilars
- Filgotinib [Jyseleca]
- Golimumab [Simponi]
- Guselkumab [Tremfya]
- Infliximab [Remicade]
- Infliximab Biosimilars
- Ixekizumab [Taltz]
- Risankizumab [Skyrizi]
- Rituximab [MabThera]
- Rituximab Biosimilars
- Sarilumab [Kevzara]
- Secukinumab [Cosentyx]
- Tocilizumab [Ro Actemra]
- Tofacitinib [Xeljanz]
- Upadacitinib [Rinvoq]
- Ustekinumab [Stelara]
Patient Count of Medication Issued in 01/02/2022 to 30/04/2022
Speciality: Rheumatology
Drug
Number of Patients
ABATACEPT
<5
ABATACEPT (ORENICA) - HOMECARE
71
ADALIMUMAB (AMGEVITA) - HOMECARE
<5
ADALIMUMAB (HUMIRA) - HOMECARE
64
ADALIMUMAB (IMRALDI) - HOMECARE
288
APREMILAST (OTEZLA) - HOMECARE
12
BARICITINIB (OLUMIANT) - HOMECARE
36
CERTOLIZUMAB (CIMZIA) - HOMECARE
18
ETANERCEPT (BENEPALI) - HOMECARE
329
ETANERCEPT (ENBREL) - HOMECARE
30
ETANERCEPT (ERELZI) - HOMECARE
<5
GOLIMUMAB (SIMPONI) - HOMECARE
117
INFLIXIMAB (INFLECTRA)
<5
INFLIXIMAB (REMICADE)
9
INFLIXIMAB (REMSIMA)
13
INFLIXIMAB (REMSIMA) - HOMECARE
12
RITUXIMAB (RIXATHON)
<5
RITUXIMAB (TRUXIMA)
15
SECUKINUMAB (COSENTYX) - HOMECARE
54
TOCILIZUMAB
25
TOCILIZUMAB (ROACTEMRA) - HOMECARE
105
TOFACITINIB(XELJANZ) - HOMECARE
<5
USTEKINUMAB (STELARA) - HOMECARE
8
*Please note if the drug has not been listed it has not been used
